Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1005 | 992 | 933 | 1157 | 1258 | - |
Fund Return | 0.54% | -0.8% | -6.71% | 4.97% | 4.7% | - |
Place in category | 2573 | 2574 | 2463 | 1191 | 935 | - |
% in Category | 97 | 96 | 97 | 62 | 66 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 2.49B | 9.65 | 7.82 | - | ||
Cleome Index USA Equities Z USD Acc | 2.49B | 6.76 | 10.40 | 12.02 | ||
RBC Lux GlblEqFocus Class C USD Cap | 1.79B | 1.00 | 6.13 | - | ||
RBC Lux GlblEqFocus Class B USD Cap | 1.79B | 0.96 | 6.02 | - | ||
Cleome Index USA Eq C USD Inc | 2.49B | 9.68 | 7.99 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzgu | 14.21B | 4.28 | 1.56 | 9.84 | ||
Cap Group New Perspective lux N USD | 14.21B | 3.82 | 0.15 | - | ||
Capital Group New Perspective Fubu | 14.21B | 4.01 | 0.79 | 8.96 | ||
Capital Group New Perspective Fubdu | 14.21B | 4.00 | 0.79 | 8.95 | ||
LU2097333152 | 14.21B | 4.38 | 1.71 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.17 | 428.77 | +0.21% | |
UnitedHealth | US91324P1021 | 5.20 | 494.32 | -0.14% | |
Anheuser Busch Inbev | BE0974293251 | 4.52 | 56.76 | -0.87% | |
T-Mobile US | US8725901040 | 4.50 | 179.42 | -0.70% | |
EOG Resources | US26875P1012 | 3.96 | 121.35 | -0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review